Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 54 of 54 entries
Sorted by: Best Match Show Resources per page
[No title available]

Genes

Gilea AI, Ceccatelli Berti C, Magistrati M, di Punzio G, Goffrini P, Baruffini E, Dallabona C.
PMID: 34946817
Genes (Basel). 2021 Nov 24;12(12). doi: 10.3390/genes12121866.

Mitochondrial DNA (mtDNA) maintenance is critical for oxidative phosphorylation (OXPHOS) since some subunits of the respiratory chain complexes are mitochondrially encoded. Pathological mutations in nuclear genes involved in the mtDNA metabolism may result in a quantitative decrease in mtDNA...

Cite
Gilea AI, Ceccatelli Berti C, Magistrati M, et al. . Genes (Basel). 2021;12(12)doi: 10.3390/genes12121866.
Gilea, A. I., Ceccatelli Berti, C., Magistrati, M., di Punzio, G., Goffrini, P., Baruffini, E., & Dallabona, C. (2021). . Genes, 12(12), . https://doi.org/10.3390/genes12121866
Gilea, Alexandru Ionut, et al. "." Genes vol. 12,12 (2021). doi: https://doi.org/10.3390/genes12121866
Gilea AI, Ceccatelli Berti C, Magistrati M, di Punzio G, Goffrini P, Baruffini E, Dallabona C. . Genes (Basel). 2021 Nov 24;12(12). doi: 10.3390/genes12121866. PMID: 34946817.
Copy Download .nbib Format: NLM
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement.

Heart and vessels

De Marzo V, Crimi G, Vercellino M, Benenati S, Pescetelli F, Della Bona R, Sarocchi M, Canepa M, Balbi M, Porto I.
PMID: 33963455
Heart Vessels. 2021 Nov;36(11):1746-1755. doi: 10.1007/s00380-021-01861-8. Epub 2021 May 07.

Peri-procedural myocardial injury (PPMI) is a common complication after transcatheter valve replacement (TAVR), often remaining clinically silent. The role of valve type on PPMI and the association between PPMI and mortality are still unclear. We sought to evaluate predictors...

Cite
De Marzo V, Crimi G, Vercellino M, et al. Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement. Heart Vessels. 2021;36(11):1746-1755doi: 10.1007/s00380-021-01861-8.
De Marzo, V., Crimi, G., Vercellino, M., Benenati, S., Pescetelli, F., Della Bona, R., Sarocchi, M., Canepa, M., Balbi, M., & Porto, I. (2021). Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement. Heart and vessels, 36(11), 1746-1755. https://doi.org/10.1007/s00380-021-01861-8
De Marzo, Vincenzo, et al. "Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement." Heart and vessels vol. 36,11 (2021): 1746-1755. doi: https://doi.org/10.1007/s00380-021-01861-8
De Marzo V, Crimi G, Vercellino M, Benenati S, Pescetelli F, Della Bona R, Sarocchi M, Canepa M, Balbi M, Porto I. Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement. Heart Vessels. 2021 Nov;36(11):1746-1755. doi: 10.1007/s00380-021-01861-8. Epub 2021 May 07. PMID: 33963455; PMCID: PMC8481174.
Copy Download .nbib Format: NLM
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients.

Clinical chemistry and laboratory medicine

Malvagia S, Ferri L, Della Bona M, Borsini W, Cirami CL, Dervishi E, Feriozzi S, Gasperini S, Motta S, Mignani R, Trezzi B, Pieruzzi F, Morrone A, Daniotti M, Donati MA, la Marca G.
PMID: 33915609
Clin Chem Lab Med. 2021 Apr 30;59(9):1516-1526. doi: 10.1515/cclm-2021-0316. Print 2021 Aug 26.

OBJECTIVES: Fabry disease (FD) is an X-linked lysosomal storage disorder, resulting from a deficiency of the enzyme α-galactosidase A, responsible for breaking down glycolipids such as globotriaosylceramide and its deacylated derivative, globotriaosylsphingosine (LysoGb3). Here, we compare the levels of...

Cite
Malvagia S, Ferri L, Della Bona M, et al. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clin Chem Lab Med. 2021;59(9):1516-1526doi: 10.1515/cclm-2021-0316.
Malvagia, S., Ferri, L., Della Bona, M., Borsini, W., Cirami, C. L., Dervishi, E., Feriozzi, S., Gasperini, S., Motta, S., Mignani, R., Trezzi, B., Pieruzzi, F., Morrone, A., Daniotti, M., Donati, M. A., & la Marca, G. (2021). Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clinical chemistry and laboratory medicine, 59(9), 1516-1526. https://doi.org/10.1515/cclm-2021-0316
Malvagia, Sabrina, et al. "Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients." Clinical chemistry and laboratory medicine vol. 59,9 (2021): 1516-1526. doi: https://doi.org/10.1515/cclm-2021-0316
Malvagia S, Ferri L, Della Bona M, Borsini W, Cirami CL, Dervishi E, Feriozzi S, Gasperini S, Motta S, Mignani R, Trezzi B, Pieruzzi F, Morrone A, Daniotti M, Donati MA, la Marca G. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clin Chem Lab Med. 2021 Apr 30;59(9):1516-1526. doi: 10.1515/cclm-2021-0316. Print 2021 Aug 26. PMID: 33915609.
Copy Download .nbib Format: NLM
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19.

Journal of geriatric cardiology : JGC

De Marzo V, Di Biagio A, Della Bona R, Vena A, Arboscello E, Emirjona H, Mora S, Giacomini M, Da Rin G, Pelosi P, Bassetti M, Ameri P, Porto I, Gecovid Study Group.
PMID: 34157060
J Geriatr Cardiol. 2021 May 28;18(5):338-345. doi: 10.11909/j.issn.1671-5411.2021.05.004.

BACKGROUND: Increases in cardiac troponin (cTn) in coronavirus disease 2019 (COVID-19) have been associated with worse prognosis. Nonetheless, data about the significance of cTn in elderly subjects with COVID-19 are lacking.METHODS: From a registry of consecutive patients with COVID-19...

Cite
De Marzo V, Di Biagio A, Della Bona R, et al. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. J Geriatr Cardiol. 2021;18(5):338-345doi: 10.11909/j.issn.1671-5411.2021.05.004.
De Marzo, V., Di Biagio, A., Della Bona, R., Vena, A., Arboscello, E., Emirjona, H., Mora, S., Giacomini, M., Da Rin, G., Pelosi, P., Bassetti, M., Ameri, P., Porto, I., & Gecovid Study Group. (2021). Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. Journal of geriatric cardiology : JGC, 18(5), 338-345. https://doi.org/10.11909/j.issn.1671-5411.2021.05.004
De Marzo, Vincenzo, et al. "Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19." Journal of geriatric cardiology : JGC vol. 18,5 (2021): 338-345. doi: https://doi.org/10.11909/j.issn.1671-5411.2021.05.004
De Marzo V, Di Biagio A, Della Bona R, Vena A, Arboscello E, Emirjona H, Mora S, Giacomini M, Da Rin G, Pelosi P, Bassetti M, Ameri P, Porto I, Gecovid Study Group. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. J Geriatr Cardiol. 2021 May 28;18(5):338-345. doi: 10.11909/j.issn.1671-5411.2021.05.004. PMID: 34157060; PMCID: PMC8185447.
Copy Download .nbib Format: NLM
Remembering Kenneth J. Anusavice.

Dental materials : official publication of the Academy of Dental Materials

Bayne SC, Thompson J, Griggs JA, Della Bona A.
PMID: 34973815
Dent Mater. 2021 Dec 29; doi: 10.1016/j.dental.2021.12.136. Epub 2021 Dec 29.

No abstract available.

Cite
Bayne SC, Thompson J, Griggs JA, et al. Remembering Kenneth J. Anusavice. Dent Mater. 2021;doi: 10.1016/j.dental.2021.12.136.
Bayne, S. C., Thompson, J., Griggs, J. A., & Della Bona, A. (2021). Remembering Kenneth J. Anusavice. Dental materials : official publication of the Academy of Dental Materials, . https://doi.org/10.1016/j.dental.2021.12.136
Bayne, Stephen C, et al. "Remembering Kenneth J. Anusavice." Dental materials : official publication of the Academy of Dental Materials vol. (2021). doi: https://doi.org/10.1016/j.dental.2021.12.136
Bayne SC, Thompson J, Griggs JA, Della Bona A. Remembering Kenneth J. Anusavice. Dent Mater. 2021 Dec 29; doi: 10.1016/j.dental.2021.12.136. Epub 2021 Dec 29. PMID: 34973815.
Copy Download .nbib Format: NLM
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis.

European heart journal. Cardiovascular pharmacotherapy

Benenati S, Crimi G, Canale C, Pescetelli F, De Marzo V, Vergallo R, Galli M, Della Bona R, Canepa M, Ameri P, Crea F, Porto I.
PMID: 33135064
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):56-64. doi: 10.1093/ehjcvp/pvaa127.

AIMS: To compare the safety and efficacy of very short (≤3 months), short (6 months), standard (12 months), and extended (>12 months) dual antiplatelet therapy (DAPT), and of subsequent monotherapies, after coronary drug-eluting stent (DES) implantation.METHODS AND RESULTS: Twenty-two...

Cite
Benenati S, Crimi G, Canale C, et al. Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022;8(1):56-64doi: 10.1093/ehjcvp/pvaa127.
Benenati, S., Crimi, G., Canale, C., Pescetelli, F., De Marzo, V., Vergallo, R., Galli, M., Della Bona, R., Canepa, M., Ameri, P., Crea, F., & Porto, I. (2022). Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis. European heart journal. Cardiovascular pharmacotherapy, 8(1), 56-64. https://doi.org/10.1093/ehjcvp/pvaa127
Benenati, Stefano, et al. "Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis." European heart journal. Cardiovascular pharmacotherapy vol. 8,1 (2022): 56-64. doi: https://doi.org/10.1093/ehjcvp/pvaa127
Benenati S, Crimi G, Canale C, Pescetelli F, De Marzo V, Vergallo R, Galli M, Della Bona R, Canepa M, Ameri P, Crea F, Porto I. Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):56-64. doi: 10.1093/ehjcvp/pvaa127. PMID: 33135064.
Copy Download .nbib Format: NLM
Showing 49 to 54 of 54 entries